Clinical trial

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

NCT00295191

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention high-flux membrane Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention low-flux membrane Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention conventional dialysate Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention ultrapure dialysate Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE4

Conditions

End-stage Renal Diseaseunresolved

Hemodialysisunresolved

Interventions

high-flux membranePROCEDURE

low-flux membranePROCEDURE

conventional dialysatePROCEDURE

ultrapure dialysatePROCEDURE

Sponsors & collaborators

Ege Universitylead sponsor

Fresenius Medical Care North Americacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00295191 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.